Patient Characteristics
| Patient No. . | Age/Sex . | Diagnosis . | Source of Stem Cells . | Conditioning Regimen . | MNCs (108/kg) . | CD34+ (106/kg) . |
|---|---|---|---|---|---|---|
| 1 | 54/M | AA | Matched sibling BM | Cy/TBI | 2.1 | 2.9 |
| 2 | 44/M | CML | Matched sibling BM | Bu/Cy | 1.4 | 2.4 |
| 3 | 50/M | NHL | Matched sibling BM | CBV | 1.9 | 2.1 |
| 4 | 51/F | AML | Matched sibling BM | Bu/Cy | 1.9 | 2.3 |
| 5 | 30/M | AML | Matched sibling PB | Flud/Ara-C | 10.5 | 6 |
| 6 | 32/M | NHL | Autologous BM + PB | CBV | 8.7 | 1 |
| 7 | 53/M | HD | Autologous BM | CBV | 2.7 | 1 |
| 8 | 47/M | NHL | Autologous BM | CBV | 2.2 | ND |
| 9 | 36/F | Breast Ca | Autologous PB | Cy/Carbo/TT | 9.1 | 2.9 |
| 10 | 66/F | Breast Ca | Autologous PB | Cy/Carbo/TT | 18 | 1.3 |
| 11 | 51/F | MM | Autologous PB CD34+ | Bu/Cy | 0.3 | 3.4 |
| Patient No. . | Age/Sex . | Diagnosis . | Source of Stem Cells . | Conditioning Regimen . | MNCs (108/kg) . | CD34+ (106/kg) . |
|---|---|---|---|---|---|---|
| 1 | 54/M | AA | Matched sibling BM | Cy/TBI | 2.1 | 2.9 |
| 2 | 44/M | CML | Matched sibling BM | Bu/Cy | 1.4 | 2.4 |
| 3 | 50/M | NHL | Matched sibling BM | CBV | 1.9 | 2.1 |
| 4 | 51/F | AML | Matched sibling BM | Bu/Cy | 1.9 | 2.3 |
| 5 | 30/M | AML | Matched sibling PB | Flud/Ara-C | 10.5 | 6 |
| 6 | 32/M | NHL | Autologous BM + PB | CBV | 8.7 | 1 |
| 7 | 53/M | HD | Autologous BM | CBV | 2.7 | 1 |
| 8 | 47/M | NHL | Autologous BM | CBV | 2.2 | ND |
| 9 | 36/F | Breast Ca | Autologous PB | Cy/Carbo/TT | 9.1 | 2.9 |
| 10 | 66/F | Breast Ca | Autologous PB | Cy/Carbo/TT | 18 | 1.3 |
| 11 | 51/F | MM | Autologous PB CD34+ | Bu/Cy | 0.3 | 3.4 |
Abbreviations: AA, aplastic anemia; CML, chronic myelogenous leukemia; NHL, non-Hodgkin’s lymphoma; AML, acute myelogenous leukemia; HD, Hodgkin’s disease; Ca, cancer; MM, multiple myeloma; BM, bone marrow; PB, peripheral blood; Cy/TBI, cyclophosphamide/total body irradiation; Bu/Cy, busulfan/cyclophosphamide; CBV, cyclophosphamide/BCNU/VP-16; Flud/Ara-c, fludarabine/Ara-c; Cy/Carbo/TT, cyclophosphamide/carboplatin/thiotepa; ND, not done.